Episode
400: Seaport's IPO adventure, obesity pill battles, and Makary's troubles
- Podcast
- The Readout Loud
- Published
- May 7, 2026
- Duration seconds
- 1989
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-readout-loud-1134305/400-seaport-s-ipo-adventure-obesity-pill-battles-and-makary-s-troubles.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
On this week’s episode of "The Readout LOUD," we chat with Seaport Therapeutics CEO Daphne Zohar, fresh off the biotech’s successful IPO. Plus, Elaine, Allison, and Adam chat about this week’s notable news, including the obesity pill battle between Eli Lilly and Novo Nordisk, a Phase 3 study win for Cytokinetics, and FDA Commissioner Marty Makary’s White House troubles. Oh, by the way, this is the 400th episode of your favorite biotech podcast.